These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 32599467)

  • 1. Dysregulation of microRNAs regulating survivin in CD4+ T cells in multiple sclerosis.
    Alizadeh-Fanalou S; Alian F; Mohammadhosayni M; Rahban D; Abbasi Ghasem Kheyli P; Ahmadi M
    Mult Scler Relat Disord; 2020 Sep; 44():102303. PubMed ID: 32599467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic polymorphisms and epigenetic regulation of survivin encoding gene, BIRC5, in multiple sclerosis patients.
    Rahban D; Mohammadi F; Alidadi M; Ghantabpour T; Kheyli PAG; Ahmadi M
    BMC Immunol; 2019 Aug; 20(1):30. PubMed ID: 31438837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. microRNAs are potentially regulating the survivin gene in PBMCs from systemic sclerosis patients.
    Ebrahimiyan H; Gharibdoost F; Aslani S; Kavosi H; Farsad F; Jamshidi A; Mahmoudi M
    Mod Rheumatol; 2020 Sep; 30(5):862-869. PubMed ID: 31441344
    [No Abstract]   [Full Text] [Related]  

  • 4. microRNA involvement in the regulation of survivin in peripheral blood mononuclear cells from rheumatoid arthritis patients.
    Ebrahimiyan H; Rezaei N; Vojdanian M; Aslani S; Jamshidi A; Mahmoudi M
    Int J Rheum Dis; 2019 Jun; 22(6):1107-1114. PubMed ID: 30834699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of miR-125a-5p and miR-218-5p in Peripheral Blood Mononuclear Cells of Patients with Relapsing-Remitting Multiple Sclerosis.
    Mosarrezaii Aghdam A; Rezaei S; Zarza Nalivan F; Babaie F; Amiri Nikpour MR; Torkamandi S
    Immunol Invest; 2022 Jul; 51(5):1149-1161. PubMed ID: 33866949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of miR-542-3p Contributes to Apoptosis Resistance in Dermal Fibroblasts from Systemic Sclerosis Patients via Survivin Overexpression.
    Vahidi Manesh P; Farazmand A; Gharibdoost F; Vanaki N; Mostafaei S; Kavosi H; Mahmoudi MB; Mahmoudi M
    Iran J Allergy Asthma Immunol; 2019 Apr; 18(2):173-181. PubMed ID: 31066253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survivin; a novel therapeutic target that correlates with survival of autoreactive T lymphocytes obtained from patients with ankylosing spondylitis.
    Shomali N; Baradaran B; Daei Sorkhabi A; Sarkesh A; Kahrizi MS; Tosan F; Mahmoodpoor A; Mardi A; Mohammadi H; Hassanzadeh A; Saeedi H; Hajialilo M; Hemmatzadeh M; Marofi F; Sandoghchian Shotorbani S
    Gene; 2022 Nov; 844():146829. PubMed ID: 35995118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Next-generation sequencing reveals broad down-regulation of microRNAs in secondary progressive multiple sclerosis CD4+ T cells.
    Sanders KA; Benton MC; Lea RA; Maltby VE; Agland S; Griffin N; Scott RJ; Tajouri L; Lechner-Scott J
    Clin Epigenetics; 2016; 8(1):87. PubMed ID: 27570566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptotic protease activating factor-1 gene and MicroRNA-484: A possible interplay in relapsing remitting multiple sclerosis.
    Mohamed DAW; Selim HM; Elmazny A; Genena A; Nabil MM
    Mult Scler Relat Disord; 2022 Feb; 58():103502. PubMed ID: 35030371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the expression of mir-34a, mir-199a, mir-30c and mir-19a in peripheral blood CD4+T lymphocytes of relapsing-remitting multiple sclerosis patients.
    Ghadiri N; Emamnia N; Ganjalikhani-Hakemi M; Ghaedi K; Etemadifar M; Salehi M; Shirzad H; Nasr-Esfahani MH
    Gene; 2018 Jun; 659():109-117. PubMed ID: 29551498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNAs expression in peripheral blood mononuclear cells of patients with multiple sclerosis propose.
    Abolghasemi M; Ali Ashrafi S; Asadi M; Shanehbandi D; Sadigh Etehad S; Poursaei E; Nejadghaderi SA; Shaafi S
    Mol Biol Rep; 2023 Jan; 50(1):167-172. PubMed ID: 36319782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-138-5p contributes to cell proliferation and invasion by targeting Survivin in bladder cancer cells.
    Yang R; Liu M; Liang H; Guo S; Guo X; Yuan M; Lian H; Yan X; Zhang S; Chen X; Fang F; Guo H; Zhang C
    Mol Cancer; 2016 Dec; 15(1):82. PubMed ID: 27978829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deregulation of microRNA expression in purified T and B lymphocytes from patients with primary Sjögren's syndrome.
    Wang-Renault SF; Boudaoud S; Nocturne G; Roche E; Sigrist N; Daviaud C; Bugge Tinggaard A; Renault V; Deleuze JF; Mariette X; Tost J
    Ann Rheum Dis; 2018 Jan; 77(1):133-140. PubMed ID: 28916716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and genetic analysis of miRNAs involved in CD4+ cell activation in patients with multiple sclerosis.
    Fenoglio C; Cantoni C; De Riz M; Ridolfi E; Cortini F; Serpente M; Villa C; Comi C; Monaco F; Mellesi L; Valzelli S; Bresolin N; Galimberti D; Scarpini E
    Neurosci Lett; 2011 Oct; 504(1):9-12. PubMed ID: 21875645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-126: a novel route for natalizumab action?
    Meira M; Sievers C; Hoffmann F; Derfuss T; Kuhle J; Kappos L; Lindberg RL
    Mult Scler; 2014 Sep; 20(10):1363-70. PubMed ID: 24598267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-27a and miR-214 exert opposite regulatory roles in Th17 differentiation via mediating different signaling pathways in peripheral blood CD4+ T lymphocytes of patients with relapsing-remitting multiple sclerosis.
    Ahmadian-Elmi M; Bidmeshki Pour A; Naghavian R; Ghaedi K; Tanhaei S; Izadi T; Nasr-Esfahani MH
    Immunogenetics; 2016 Jan; 68(1):43-54. PubMed ID: 26563334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect miR-214-3p on proliferation and apoptosis of breast cancer cells by targeting survivin protein.
    Han LC; Wang H; Niu FL; Yan JY; Cai HF
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7469-7474. PubMed ID: 31539134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-132-3p, miR-106b-5p, and miR-19b-3p Are Associated with Brain-Derived Neurotrophic Factor Production and Clinical Activity in Multiple Sclerosis: A Pilot Study.
    Sağır F; Ersoy Tunalı N; Tombul T; Koral G; Çırak S; Yılmaz V; Türkoğlu R; Tüzün E
    Genet Test Mol Biomarkers; 2021 Nov; 25(11):720-726. PubMed ID: 34788141
    [No Abstract]   [Full Text] [Related]  

  • 19. Expression, regulation and function of microRNAs in multiple sclerosis.
    Ma X; Zhou J; Zhong Y; Jiang L; Mu P; Li Y; Singh N; Nagarkatti M; Nagarkatti P
    Int J Med Sci; 2014; 11(8):810-8. PubMed ID: 24936144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-494 Sensitizes Gastric Cancer Cells to TRAIL Treatment Through Downregulation of Survivin.
    Xu S; Li D; Li T; Qiao L; Li K; Guo L; Liu Y
    Cell Physiol Biochem; 2018; 51(5):2212-2223. PubMed ID: 30537730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.